1226895-15-3,MFCD27976793
Catalog No.:AA009VQ6

1226895-15-3 | Flll32

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
97%
in stock  
$19.00   $14.00
- +
5mg
97%
in stock  
$50.00   $35.00
- +
25mg
97%
in stock  
$115.00   $81.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA009VQ6
Chemical Name:
Flll32
CAS Number:
1226895-15-3
Molecular Formula:
C28H32O6
Molecular Weight:
464.5501
MDL Number:
MFCD27976793
SMILES:
COc1cc(/C=C/C(=O)C2(CCCCC2)C(=O)/C=C/c2ccc(c(c2)OC)OC)ccc1OC
Properties
Computed Properties
 
Complexity:
668  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
2  
Formal Charge:
0  
Heavy Atom Count:
34  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
10  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
5.8  

Downstream Synthesis Route

[1]Patent:WO2010/121007,2010,A1.Locationinpatent:Page/Pagecolumn5;14-15

Literature

Title: Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice.

Journal: Investigational new drugs 20120601

Title: Structurally modified curcumin analogs inhibit STAT3 phosphorylation and promote apoptosis of human renal cell carcinoma and melanoma cell lines.

Journal: PloS one 20120101

Title: STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH⁺/CD133⁺ stem cell-like human colon cancer cells.

Journal: Biochemical and biophysical research communications 20111216

Title: Sensitization of head and neck cancer to cisplatin through the use of a novel curcumin analog.

Journal: Archives of otolaryngology--head & neck surgery 20110501

Title: Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells.

Journal: International journal of oncology 20110101

Title: The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines.

Journal: BMC cancer 20110101

Title: IL-6, a risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-induced STAT3 phosphorylation in human hepatocellular cancer cells.

Journal: Cell cycle (Georgetown, Tex.) 20100901

Title: Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.

Journal: Cancer research 20100315

Title: The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity.

Journal: Molecular cancer 20100101

Title: A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells.

Journal: Molecular cancer 20100101

Title: Bill MA, et al. The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3inhibition and retains the cellular response to cytokines with anti-tumor activity. Mol Cancer. 2010 Jun 25;9:165.

Title: Lin L, et al. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreaticand breast cancer cells. Cancer Res. 2010 Mar 15;70(6):2445-54.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1226895-15-3 Molecular Formula|1226895-15-3 MDL|1226895-15-3 SMILES|1226895-15-3 Flll32
Catalog No.: AA009VQ6
1226895-15-3,MFCD27976793
1226895-15-3 | Flll32
Pack Size: 1mg
Purity: 97%
in stock
$19.00 $14.00
Pack Size: 5mg
Purity: 97%
in stock
$50.00 $35.00
Pack Size: 25mg
Purity: 97%
in stock
$115.00 $81.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA009VQ6
Chemical Name: Flll32
CAS Number: 1226895-15-3
Molecular Formula: C28H32O6
Molecular Weight: 464.5501
MDL Number: MFCD27976793
SMILES: COc1cc(/C=C/C(=O)C2(CCCCC2)C(=O)/C=C/c2ccc(c(c2)OC)OC)ccc1OC
Properties
Complexity: 668  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 2  
Formal Charge: 0  
Heavy Atom Count: 34  
Hydrogen Bond Acceptor Count: 6  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 10  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 5.8  
Downstream Synthesis Route
628-77-3    160096-59-3    1226895-15-3 

[1]Patent:WO2010/121007,2010,A1.Locationinpatent:Page/Pagecolumn5;14-15

Literature fold

Title: Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice.

Journal: Investigational new drugs20120601

Title: Structurally modified curcumin analogs inhibit STAT3 phosphorylation and promote apoptosis of human renal cell carcinoma and melanoma cell lines.

Journal: PloS one20120101

Title: STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH⁺/CD133⁺ stem cell-like human colon cancer cells.

Journal: Biochemical and biophysical research communications20111216

Title: Sensitization of head and neck cancer to cisplatin through the use of a novel curcumin analog.

Journal: Archives of otolaryngology--head & neck surgery20110501

Title: Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells.

Journal: International journal of oncology20110101

Title: The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines.

Journal: BMC cancer20110101

Title: IL-6, a risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-induced STAT3 phosphorylation in human hepatocellular cancer cells.

Journal: Cell cycle (Georgetown, Tex.)20100901

Title: Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.

Journal: Cancer research20100315

Title: The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity.

Journal: Molecular cancer20100101

Title: A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells.

Journal: Molecular cancer20100101

Title: Bill MA, et al. The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3inhibition and retains the cellular response to cytokines with anti-tumor activity. Mol Cancer. 2010 Jun 25;9:165.

Title: Lin L, et al. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreaticand breast cancer cells. Cancer Res. 2010 Mar 15;70(6):2445-54.

Building Blocks More >
142340-15-6
142340-15-6
5-Iodoquinolin-8-amine
AA009WGU | MFCD24160460
126534-36-9
126534-36-9
(S)-1-(2,5-difluorophenyl)ethanol
AA009WKG | MFCD09863773
1261902-83-3
1261902-83-3
2-(4-Methoxyphenyl)-6-methylbenzoic acid
AA009WQ8 | MFCD18319515
1393442-65-3
1393442-65-3
5-Bromo-6,7-difluoro-1-methylbenzotriazole
AA009WTQ | MFCD22383709
1262009-62-0
1262009-62-0
2-Chloro-5-(3-methoxycarbonylphenyl)benzoic acid
AA009WXL | MFCD18321210
1393441-67-2
1393441-67-2
N-Cbz-N'-isopropyl-DL-phenylglycinamide
AA009X1H | MFCD22383743
1242268-09-2
1242268-09-2
Methyl 4-amino-3-(ethylamino)benzoate
AA009X51 | MFCD16710286
132219-51-3
132219-51-3
1-(6-Chloropyridin-3-yl)ethanamine
AA009XEZ | MFCD13188898
1289194-02-0
1289194-02-0
6-Hydroxy-5-methylpyridine-3-carbaldehyde
AA009Y1Q | MFCD21087785
1256791-52-2
1256791-52-2
2-Methyl-6-(trifluoromethyl)pyridin-3-ol
AA009Y8O | MFCD18255966
Submit
© 2017 AA BLOCKS, INC. All rights reserved.